Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alter

Showing results (271-280 of 658) with videos related to

Pageof 66
Sort By:
ASAIO Transactions|April 1, 1991
National surveillance of dialysis-associated diseases in the United States, 1989M J Alter, M S Favero, L A Moyer, et al.
Nature: New Biology|April 25, 1973
Lymphocyte reactivity to serologically undetected components of the major histocompatibility complexM B Widmer, B J Alter, F H Bach, et al.
Ophthalmology|November 1, 1985
Laser interferometry and visual prognosis in uveitisA G Palestine, G J Alter, C C Chan, et al.
Partner Abuse|March 25, 2022
Problem Drinking and Marijuana Use as Risks for Unidirectional and Bidirectional Partner ViolenceCarol B Cunradi, Elinam Dellor, Harrison J Alter, et al.
Microsurgery|January 1, 1995
Prosthetic implantation after phallic constructionG J Alter, D A Gilbert, S M Schlossberg, et al.
European Journal of Immunology|November 1, 1977
Cell-free factor substitute for "signal 2" in generating cytotoxic reactionsM L Sopori, B J Alter, F H Bach, et al.
Vox Sanguinis|January 1, 1977
Subtypes of HBsAg in eastern and south-eastern EuropeK Madaliński, P V Holland, Z Moraczewska, et al.
Transfusion|February 14, 2004
Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCVS L Orton, S L Stramer, R Y Dodd, et al.
Vaccine|January 23, 1999
Hepatitis B vaccination of adolescent and adult high-risk groups in the United StatesE E Mast, I T Williams, M J Alter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1976
The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAgD E Koziol, H J Alter, J P Kirchner, et al.
Pageof 66

Showing results (271-280 of 658) with videos related to

Sort By:
Pageof 66
ASAIO Transactions|April 1, 1991
National surveillance of dialysis-associated diseases in the United States, 1989M J Alter, M S Favero, L A Moyer, et al.
Nature: New Biology|April 25, 1973
Lymphocyte reactivity to serologically undetected components of the major histocompatibility complexM B Widmer, B J Alter, F H Bach, et al.
Ophthalmology|November 1, 1985
Laser interferometry and visual prognosis in uveitisA G Palestine, G J Alter, C C Chan, et al.
Partner Abuse|March 25, 2022
Problem Drinking and Marijuana Use as Risks for Unidirectional and Bidirectional Partner ViolenceCarol B Cunradi, Elinam Dellor, Harrison J Alter, et al.
Microsurgery|January 1, 1995
Prosthetic implantation after phallic constructionG J Alter, D A Gilbert, S M Schlossberg, et al.
European Journal of Immunology|November 1, 1977
Cell-free factor substitute for "signal 2" in generating cytotoxic reactionsM L Sopori, B J Alter, F H Bach, et al.
Vox Sanguinis|January 1, 1977
Subtypes of HBsAg in eastern and south-eastern EuropeK Madaliński, P V Holland, Z Moraczewska, et al.
Transfusion|February 14, 2004
Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCVS L Orton, S L Stramer, R Y Dodd, et al.
Vaccine|January 23, 1999
Hepatitis B vaccination of adolescent and adult high-risk groups in the United StatesE E Mast, I T Williams, M J Alter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1976
The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAgD E Koziol, H J Alter, J P Kirchner, et al.
Pageof 66